{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:02:58Z","timestamp":1790427778995,"version":"4.1.0"},"reference-count":41,"publisher":"Portland Press Ltd.","issue":"13","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,16]]},"abstract":"<jats:p>The COVID-19 pandemic has presented itself as one of the most critical public health challenges of the century, with SARS-CoV-2 being the third member of the Coronaviridae family to cause a fatal disease in humans. There is currently only one antiviral compound, remdesivir, that can be used for the treatment of COVID-19. To identify additional potential therapeutics, we investigated the enzymatic proteins encoded in the SARS-CoV-2 genome. In this study, we focussed on the viral RNA cap methyltransferases, which play key roles in enabling viral protein translation and facilitating viral escape from the immune system. We expressed and purified both the guanine-N7 methyltransferase nsp14, and the nsp16 2\u2032-O-methyltransferase with its activating cofactor, nsp10. We performed an in vitro high-throughput screen for inhibitors of nsp14 using a custom compound library of over 5000 pharmaceutical compounds that have previously been characterised in either clinical or basic research. We identified four compounds as potential inhibitors of nsp14, all of which also showed antiviral capacity in a cell-based model of SARS-CoV-2 infection. Three of the four compounds also exhibited synergistic effects on viral replication with remdesivir.<\/jats:p>","DOI":"10.1042\/bcj20210219","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:19:53Z","timestamp":1625167193000},"page":"2481-2497","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase"],"prefix":"10.1042","volume":"478","author":[{"given":"Souradeep","family":"Basu","sequence":"first","affiliation":[{"name":"Cell Cycle Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Mak","sequence":"additional","affiliation":[{"name":"Cell Cycle Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ulferts","sequence":"additional","affiliation":[{"name":"Cell Biology of Infection Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Wu","sequence":"additional","affiliation":[{"name":"High Throughput Screening, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Deegan","sequence":"additional","affiliation":[{"name":"The MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"The MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang Wei","family":"Tan","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chew Theng","family":"Lim","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis","family":"Basier","sequence":"additional","affiliation":[{"name":"Cell Cycle Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Canal","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Curran","sequence":"additional","affiliation":[{"name":"Cell Cycle Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy S.","family":"Drury","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison W.","family":"McClure","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Cell Cycle Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Weissmann","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa U.","family":"Zeisner","sequence":"additional","affiliation":[{"name":"Cell Cycle Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Beale","sequence":"additional","affiliation":[{"name":"Cell Biology of Infection Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria H.","family":"Cowling","sequence":"additional","affiliation":[{"name":"Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Howell","sequence":"additional","affiliation":[{"name":"High Throughput Screening, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-379X","authenticated-orcid":false,"given":"Karim","family":"Labib","sequence":"additional","affiliation":[{"name":"The MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-7680","authenticated-orcid":false,"given":"John F.X.","family":"Diffley","sequence":"additional","affiliation":[{"name":"Chromosome Replication Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"2021112218234596200_BCJ-2021-0219C1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","article-title":"WHO declares COVID-19 a pandemic","volume":"91","year":"2020","journal-title":"Acta Biomed."},{"key":"2021112218234596200_BCJ-2021-0219C2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"2021112218234596200_BCJ-2021-0219C3","doi-asserted-by":"publisher","first-page":"115094","DOI":"10.1016\/j.diagmicrobio.2020.115094","article-title":"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the coronavirus disease 2019 (COVID-19), a comprehensive literature review","volume":"98","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"2021112218234596200_BCJ-2021-0219C4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"2021112218234596200_BCJ-2021-0219C5","doi-asserted-by":"crossref","unstructured":"Singer, J., Gifford, R.,Cotten, M. and Robertson, D. (2020) CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. Preprints","DOI":"10.20944\/preprints202006.0225.v1"},{"key":"2021112218234596200_BCJ-2021-0219C6","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","volume":"184","year":"2021","journal-title":"Cell"},{"key":"2021112218234596200_BCJ-2021-0219C7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","article-title":"The coding capacity of SARS-CoV-2","volume":"589","year":"2021","journal-title":"Nature"},{"key":"2021112218234596200_BCJ-2021-0219C8","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1093\/nar\/gkw551","article-title":"mRNA capping: biological functions and applications","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2021112218234596200_BCJ-2021-0219C9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/0042-6822(77)90482-2","article-title":"5\u2032-termini of reovirus mRNA: ability of viral cores to form caps post-transcriptionally","volume":"77","year":"1977","journal-title":"Virology"},{"key":"2021112218234596200_BCJ-2021-0219C10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0079-6603(00)66025-7","article-title":"Structure, mechanism, and evolution of the mRNA capping apparatus","volume":"66","year":"2001","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"2021112218234596200_BCJ-2021-0219C11","doi-asserted-by":"publisher","first-page":"10054","DOI":"10.1016\/S0021-9258(19)68740-5","article-title":"Post-transcriptional modifications of mRNA. Purification and characterization of cap I and cap II RNA (nucleoside-2\u2032-)-methyltransferases from heLa cells","volume":"256","year":"1981","journal-title":"J. Biol. Chem."},{"key":"2021112218234596200_BCJ-2021-0219C12","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1128\/JVI.00542-16","article-title":"Mutagenesis of S-adenosyl-l-methionine-binding residues in coronavirus nsp14 N7-methyltransferase demonstrates differing requirements for genome translation and resistance to innate immunity","volume":"90","year":"2016","journal-title":"J. Virol."},{"key":"2021112218234596200_BCJ-2021-0219C13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1083\/jcb.200309008","article-title":"Cytoplasmic foci are sites of mRNA decay in human cells","volume":"165","year":"2004","journal-title":"J. Cell Biol."},{"key":"2021112218234596200_BCJ-2021-0219C14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.sbi.2005.01.009","article-title":"Processing the message: structural insights into capping and decapping mRNA","volume":"15","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2021112218234596200_BCJ-2021-0219C15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","year":"2006","journal-title":"Nat. Immunol."},{"key":"2021112218234596200_BCJ-2021-0219C16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni.1979","article-title":"Ribose 2\u2032-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5","volume":"12","year":"2011","journal-title":"Nat. Immunol."},{"key":"2021112218234596200_BCJ-2021-0219C17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2\u2032-O methylation of the viral mRNA cap evades host restriction by IFIT family members","volume":"468","year":"2010","journal-title":"Nature"},{"key":"2021112218234596200_BCJ-2021-0219C18","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","year":"2009","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021112218234596200_BCJ-2021-0219C19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cytogfr.2014.05.002","article-title":"IFIT1: a dual sensor and effector molecule that detects non-2\u2032-O methylated viral RNA and inhibits its translation","volume":"25","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"2021112218234596200_BCJ-2021-0219C20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.virusres.2014.09.009","article-title":"Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments","volume":"194","year":"2014","journal-title":"Virus Res."},{"key":"2021112218234596200_BCJ-2021-0219C21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbagrm.2018.09.011","article-title":"mRNA cap regulation in mammalian cell function and fate","volume":"1862","year":"2019","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"2021112218234596200_BCJ-2021-0219C22","doi-asserted-by":"publisher","first-page":"9372","DOI":"10.1073\/pnas.1201130109","article-title":"RNA 3\u2032-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10\/nsp14 exoribonuclease complex","volume":"109","year":"2012","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021112218234596200_BCJ-2021-0219C23","doi-asserted-by":"publisher","first-page":"e1002059","DOI":"10.1371\/journal.ppat.1002059","article-title":"Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2\u2032-O-methyltransferase nsp10\/nsp16 complex","volume":"7","year":"2011","journal-title":"PLoS Pathog."},{"key":"2021112218234596200_BCJ-2021-0219C24","doi-asserted-by":"publisher","first-page":"eabe1202","DOI":"10.1126\/scisignal.abe1202","article-title":"High-resolution structures of the SARS-CoV-2 2\u2032-O-methyltransferase reveal strategies for structure-based inhibitor design","volume":"13","year":"2020","journal-title":"Sci. Signal."},{"key":"2021112218234596200_BCJ-2021-0219C25","doi-asserted-by":"publisher","first-page":"112557","DOI":"10.1016\/j.ejmech.2020.112557","article-title":"Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase","volume":"201","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"2021112218234596200_BCJ-2021-0219C26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.cell.2014.07.050","article-title":"Key steps in ERAD of luminal ER proteins reconstituted with purified components","volume":"158","year":"2014","journal-title":"Cell"},{"key":"2021112218234596200_BCJ-2021-0219C27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.virusres.2013.05.001","article-title":"Characterization of the guanine-N7 methyltransferase activity of coronavirus nsp14 on nucleotide GTP","volume":"176","year":"2013","journal-title":"Virus Res."},{"key":"2021112218234596200_BCJ-2021-0219C28","doi-asserted-by":"publisher","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","volume":"112","year":"2015","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"2021112218234596200_BCJ-2021-0219C29","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20210201","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase","volume":"487","year":"2021","journal-title":"Biochem. J."},{"key":"2021112218234596200_BCJ-2021-0219C30","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20210199","article-title":"Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease","volume":"478","year":"2021","journal-title":"Biochem. J."},{"key":"2021112218234596200_BCJ-2021-0219C31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"2021112218234596200_BCJ-2021-0219C32","doi-asserted-by":"publisher","first-page":"e1002294","DOI":"10.1371\/journal.ppat.1002294","article-title":"Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2\u2032-O-methylation by nsp16\/nsp10 protein complex","volume":"7","year":"2011","journal-title":"PLoS Pathog."},{"key":"2021112218234596200_BCJ-2021-0219C33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021112218234596200_BCJ-2021-0219C34","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/sj.bjc.6604366","article-title":"A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer","volume":"98","year":"2008","journal-title":"Br. J. Cancer"},{"key":"2021112218234596200_BCJ-2021-0219C35","unstructured":"A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy. 2012; Available from: https:\/\/ClinicalTrials.gov\/show\/NCT01488877"},{"key":"2021112218234596200_BCJ-2021-0219C36","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1158\/1078-0432.CCR-05-2198","article-title":"Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors","volume":"12","year":"2006","journal-title":"Clin Cancer Res."},{"key":"2021112218234596200_BCJ-2021-0219C37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fphar.2013.00115","article-title":"PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy","volume":"4","year":"2013","journal-title":"Front. Pharmacol."},{"key":"2021112218234596200_BCJ-2021-0219C38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/emmm.201100211","article-title":"A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53","volume":"4","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"2021112218234596200_BCJ-2021-0219C39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2021112218234596200_BCJ-2021-0219C40","doi-asserted-by":"publisher","first-page":"e60371","DOI":"10.7554\/eLife.60371","article-title":"CMG helicase disassembly is controlled by replication fork DNA, replisome components and a ubiquitin threshold","volume":"9","year":"2020","journal-title":"eLife"},{"key":"2021112218234596200_BCJ-2021-0219C41","doi-asserted-by":"publisher","first-page":"10423","DOI":"10.1093\/nar\/gkw637","article-title":"Molecular basis of RNA guanine-7 methyltransferase (RNMT) activation by RAM","volume":"44","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/478\/13\/2481\/915881\/bcj-2021-0219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/478\/13\/2481\/915881\/bcj-2021-0219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T21:35:46Z","timestamp":1637616946000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/478\/13\/2481\/229153\/Identifying-SARS-CoV-2-antiviral-compounds-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,7,16]]}},"URL":"https:\/\/doi.org\/10.1042\/bcj20210219","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.07.438810","asserted-by":"object"}]},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]}}}